Publication | Closed Access
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
34
Citations
42
References
2008
Year
MedicinePharmacologyPathologyLiver CancerAnti-cancer AgentCancer TreatmentOncologyCancer ResearchHepatocellular CarcinomaTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1